News
News Center
2025-01-21
Although currently only one product has been approved domestically, there are still many companies actively developing stem cell therapies. According to an incomplete tally by the People's Daily Health Client, more than 30 companies received approval in 2024 to proceed with clinical trials for new drugs, including well-known firms such as Tasly, Jiuzhitang Maker, Qilu Cell, and Quansheng Bio. These therapies primarily target conditions affecting the blood system, cardiovascular system, nervous system, respiratory system, and autoimmune disorders.
+
2025-01-03
Big news! China's first stem-cell therapy drug approved for market.
The approval of "Amy Maitosai" marks a significant milestone in China’s stem-cell therapy field. This breakthrough not only offers hope to patients who urgently need effective treatment options but also represents an important step forward for China’s stem-cell therapies in both clinical application and commercialization.
+
2024-12-20
Milestone Event: Mesoblast’s stem-cell drug receives FDA approval for market launch
This is not only a victory for Mesoblast—but a milestone for the entire stem cell industry. It inspires Jiuzhitang Maker and stem cell R&D companies around the globe to keep pushing forward, collectively advancing the development of stem cell therapies and contributing even more to the cause of human health.
+
2024-06-27
Recently, China Economic Weekly, the official and authoritative platform of the People's Daily, published an article titled "Cell Therapy Ushers in a New Era for Treating Complex and Intractable Diseases." The article clearly highlights that, thanks to continuous scientific breakthroughs and innovation, modern medicine is undergoing a historic transformation—from relying on traditional treatment methods toward more advanced, cutting-edge cell therapies—marking a critical step forward in humanity's fight against challenging and complex illnesses.
+
2024-06-18
Mesoblast's Ups and Downs: Part 1
Stem cell drugs represent a new class of medications that go beyond traditional small-molecule drugs, featuring complex products with multiple active properties. For any stem cell pharmaceutical company aiming to gain approval from regulatory authorities and secure market authorization for its stem cell therapies, it’s crucial to address the specific concerns raised by the FDA regarding Mesoblast—particularly in areas such as quality stability, pharmacodynamic studies, and clinical efficacy—and provide robust, data-driven evidence to support these claims.
+
2024-01-24
The "father of bone marrow mesenchymal stem cells" passes away
The pivotal moment in his career came when he successfully isolated human mesenchymal stem cells (MSCs) from adult bone marrow, laying the conceptual and technical groundwork for subsequent global research.
+
2023-12-11
Fitness superstar Chris: Undergoing stem cell therapy as kidney issues raise concerns.
Recently, foreign media reported that international bodybuilding superstar Chris is undergoing stem-cell therapy, aimed at preventing potential future health issues.
+
2023-11-21
“Standards provide a valuable reference for both research and application, serving as a fundamental guarantee for industry development,” said Ji Weizhi, an academician of the Chinese Academy of Sciences and director of the Primate Translational Medicine Research Institute at Kunming University of Science and Technology. He added that currently, developing standards in the stem cell field still faces significant challenges. However, as research into stem cell theories and technologies continues to advance, he believes more innovative standards will emerge—while existing ones will be refined further—to better propel progress in this cutting-edge area.
+![[Science and Technology Daily] Stem cell research could spark a revolution in medical technology](https://omo-oss-image.thefastimg.com/portal-saas/pg2024091209142318355/cms/image/ca716faf-6406-4d84-a280-c55d825e77a3.png "[Science and Technology Daily] Stem cell research could spark a revolution in medical technology")
2023-08-07
[Science and Technology Daily] Stem cell research could spark a revolution in medical technology
In recent years, rapidly advancing technologies such as spatial omics, single-cell spatiotemporal genomics sequencing, single-molecule techniques, ultra-sensitive proteomics analysis, and proximity labeling approaches have significantly propelled stem cell research, providing the technological foundation needed to achieve functional organ reconstruction.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy